Skip to main content

Clomiphene

ADVERTISEMENT
Identification
Molecular formula
C26H28ClNO
CAS number
15690-57-9
IUPAC name
2-(1-azatricyclo[7.3.1.05,13]trideca-5,7,9(13)-trien-7-ylmethylene)propanedinitrile
State
State
Clomiphene is typically in a solid state at room temperature, often provided in tablet form for pharmaceutical applications.
Melting point (Celsius)
116.00
Melting point (Kelvin)
389.15
Boiling point (Celsius)
510.00
Boiling point (Kelvin)
783.15
General information
Molecular weight
405.97g/mol
Molar mass
405.9670g/mol
Density
1.0400g/cm3
Appearence

Clomiphene is generally available as a white to pale yellow, crystalline powder. It does not have a specific odor and is often supplied in tablets for medical use, particularly in fertility treatments.

Comment on solubility

Solubility of 2-(1-azatricyclo[7.3.1.05,13]trideca-5,7,9(13)-trien-7-ylmethylene)propanedinitrile

The solubility of the compound 2-(1-azatricyclo[7.3.1.05,13]trideca-5,7,9(13)-trien-7-ylmethylene)propanedinitrile, represented by the chemical formula C26H28ClNO, can be quite intricate due to its unique molecular structure. To appreciate its solubility characteristics, it is crucial to consider various factors:

  • Polarity: The presence of both polar (nitrile groups) and non-polar (hydrocarbon chains) components can lead to variable solubility in different solvents.
  • Solvent Interaction: This compound may exhibit modest solubility in organic solvents, such as ethanol or dimethyl sulfoxide (DMSO), yet it is likely insoluble in water due to its hydrophobic characteristics.
  • Concentration Dependency: The solubility may change with concentration; at higher concentrations, precipitation might occur.

In conclusion, while the specific solubility data of this compound is not extensively documented, it is rational to predict that its behavior in solution will present intriguing challenges for experimental work and practical applications. Solubility testing in various solvents is essential to ascertain its precise solubility profile.

Interesting facts

Fascinating Insights into 2-(1-azatricyclo[7.3.1.05,13]trideca-5,7,9(13)-trien-7-ylmethylene)propanedinitrile

The compound 2-(1-azatricyclo[7.3.1.05,13]trideca-5,7,9(13)-trien-7-ylmethylene)propanedinitrile is a remarkable example of structural complexity in organic chemistry. Here are some interesting aspects of this intriguing compound:

  • Unique Architecture: This compound features a rare bicyclic structure with a tricyclic framework, highlighting the diverse structural possibilities in organic molecules.
  • Applications in Drug Design: Due to its unique structural characteristics, compounds like this one can serve as potential leads for novel pharmaceuticals, especially in targeting specific biological responses.
  • Potential Biological Activity: Related compounds have demonstrated interesting biological properties, making the exploration of such structures essential in medicinal chemistry.
  • Synthesis Challenges: The synthesis of this molecule involves intricate sequences and conditions, showcasing creativity and precision in laboratory practices.
  • Research Interest: Its fascinating structure has piqued the interest of chemists and researchers, leading to numerous studies aimed at exploring its properties and functionalities.

In the words of renowned chemist Linus Pauling, "The best way to have a good idea is to have a lot of ideas." This sentiment rings true as the exploration of compounds like 2-(1-azatricyclo[7.3.1.05,13]trideca-5,7,9(13)-trien-7-ylmethylene)propanedinitrile opens up new avenues in chemical research and discovery.

With every new insight gained from studying such compounds, the horizon of chemical science broadens, leading to groundbreaking innovations in various fields including pharmaceuticals, materials science, and more.

Synonyms
dcvj
58293-56-4
9-(2,2-Dicyanovinyl)julolidine
2-(1-azatricyclo[7.3.1.05,13]trideca-5,7,9(13)-trien-7-ylmethylidene)propanedinitrile
2-((1,2,3,5,6,7-hexahydropyrido[3,2,1-ij]quinolin-9-yl)methylene)malononitrile
9-Julolidinylmethylenemalononitrile
2-[(2,3,6,7-Tetrahydro-1H,5H-benzo[ij]quinolizin-9-yl)methylene]propanedinitrile(Dicyanovinyl)julolidine; 9-(Dicyanovinyl)julolidine; DCVJ; Julolidinemalononitrile; NSC 160064; [(2,3,6,7-Tetrahydro-1H,5H-benzo[ij]quinolizin-9-yl)methylene]-propanedinitrile
MFCD01747392
julolidinemalononitrile
4-Dicyanovinyljulolidine
9-(dicyanovinyl)-julolidine
Oprea1_822218
SCHEMBL597755
9-yl)methylene]propanedinitrile
DTXSID90973835
HY-D1425
EX-A10939
NSC160064
AKOS015916467
NSC-160064
2-((2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinolin-9-yl)methylene)malononitrile
AS-55814
CS-0374377
D5971
D96061
[(2,3,6,7-Tetrahydro-1H,5H-pyrido[3,2,1-ij]quinolin-9-yl)methylidene]propanedinitrile
2-({1-azatricyclo[7.3.1.0?,??]trideca-5,7,9(13)-trien-7-yl}methylidene)propanedinitrile
9-(2,2-Dicyanovinyl)julolidine, BioReagent, suitable for fluorescence, >=97.0% (HPLC)
2-{1-AZATRICYCLO[7.3.1.0?,(1)(3)]TRIDECA-5,7,9(13)-TRIEN-7-YLMETHYLIDENE}PROPANEDINITRILE
634-668-5